Total Assets - VistaGen Therapeutics Inc (NASDAQ:VTGN) - Alpha Spread
V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 3 USD Market Closed
Market Cap: 81.2m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

VistaGen Therapeutics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

VistaGen Therapeutics Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
V
VistaGen Therapeutics Inc
NASDAQ:VTGN
Total Assets
$113.5m
CAGR 3-Years
3%
CAGR 5-Years
54%
CAGR 10-Years
64%
Abbvie Inc
NYSE:ABBV
Total Assets
$141.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$53.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$20.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$36.1B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is VistaGen Therapeutics Inc's Total Assets?
Total Assets
113.5m USD

Based on the financial report for Jun 30, 2024, VistaGen Therapeutics Inc's Total Assets amounts to 113.5m USD.

What is VistaGen Therapeutics Inc's Total Assets growth rate?
Total Assets CAGR 10Y
64%

Over the last year, the Total Assets growth was 657%. The average annual Total Assets growth rates for VistaGen Therapeutics Inc have been 3% over the past three years , 54% over the past five years , and 64% over the past ten years .

Back to Top